Logo do repositório
 
Publicação

Evaluation of radiotherapy doses in pediatric patients with Hodgkin Lymphoma: Monte Carlo Simulations

2025-10-14Comunicação em conferência Acesso aberto
Ver registo simples
dc.contributor.authorMota, Inês
dc.contributor.authorSá, Ana Cravo
dc.contributor.authorCosta, Fernando
dc.contributor.authorMonteiro, Armanda
dc.contributor.authorAires, Fátima
dc.contributor.authorFaria, Isabel
dc.date.accessioned2026-04-21T12:38:15Z
dc.date.available2026-04-21T12:38:15Z
dc.date.issued2025-10-14
dc.description.abstractHodgkin Lymphoma (HL) is one of the most common cancers in children, and radiotherapy (RT) is a crucial part of treatment. However, the risk of late effects, such as cardiotoxicity and secondary malignant neoplasms, is a concern due to radiation exposure to critical organs[2-8]. Advanced dose calculation methods, such as Monte Carlo Methods (MCMs), can improve dosimetry accuracy and help minimize these risks[9,10]. This study aims to assess organ doses in pediatric patients undergoing RT for HL. The research was structured into three main components: a systematic literature review, dose calculations using the Eclipse treatment planning system and simulations using the PRIMO software. Information was collected from the Pubmed database on the effect of doses on the organs of pediatric patients undergoing RT for HL. The search terms and the Boolean operator were used in the following search query: ((Hodgkin) AND (Late effects)) AND (Pediatric). A total of 17 articles were considered. PRIMO simulations showed greater accuracy with lower uncertainties than Eclipse. PRIMO calculated a heart dose of 1645 mGy, while Eclipse estimated 2142 mGy. For the breasts, PRIMO calculated 243 mGy versus 189 mGy in Eclipse. Though small, these differences may have clinical relevance, as studies indicate that doses above 20-30 Gy raise the risk of late effects like breast cancer and cardiotoxicity. PRIMO’s precision makes it more reliable for assessing pediatric radiation exposure, where accurate dosimetry is key to minimizing long-term risks. The comparative analysis showed that PRIMO, using MCMs offers more detailed and accurate dose calculations than Eclipse TPS. Incorporating MCMs into clinical protocols can improve the assessment of radiation risks and better protect critical organs, promoting safer and more effective treatment for pediatric HL patients.eng
dc.identifier.citationMota, I., Cravo Sá, A., Costa, F., Monteiro, A., Aires, F., & Faria, I. (2025). Evaluation of radiotherapy doses in pediatric patients with Hodgkin Lymphoma: Monte Carlo Simulations. Proceedings of Research and Practice in Allied and Environmental Health, 2(4), 27–28. https://doi.org/10.26537/prpaeh.v2i4.6500
dc.identifier.doi10.26537/prpaeh.v2i4.6500
dc.identifier.issn2975-9420
dc.identifier.urihttp://hdl.handle.net/10400.22/32245
dc.language.isoeng
dc.peerreviewedyes
dc.publisherIPP
dc.relation.hasversionhttps://parc.ipp.pt/index.php/PRPAEH/article/view/6500
dc.rights.uriN/A
dc.subjectRadiotherapy
dc.subjectPediatrics
dc.subjectHodgkin Lymphoma
dc.titleEvaluation of radiotherapy doses in pediatric patients with Hodgkin Lymphoma: Monte Carlo Simulationseng
dc.typeconference paper
dspace.entity.typePublication
oaire.citation.conferenceDate2024-12-19
oaire.citation.conferencePlacePorto
oaire.citation.endPage28
oaire.citation.issue4
oaire.citation.startPage27
oaire.citation.titleProceedings of Research and Practice in Allied and Environmental Health - II Jornadas TSDT do Hospital de São João
oaire.citation.volume2
oaire.versionhttp://purl.org/coar/version/c_970fb48d4fbd8a85

Ficheiros

Coleções

ESS - CISA/LAQV Requimte - Comunicações em eventos científicos
ESS - RADT - Comunicações em eventos científicos
ESS - TBIO/Rise Health - Comunicações em eventos científicos